Invention Grant
US08258095B2 Method of controlling glycemia by ultrarapid acting insulin without adjusting an insulin dose for meal content
有权
通过超临界作用胰岛素控制血糖的方法，而不调整膳食含量的胰岛素剂量
- Patent Title: Method of controlling glycemia by ultrarapid acting insulin without adjusting an insulin dose for meal content
- Patent Title (中): 通过超临界作用胰岛素控制血糖的方法，而不调整膳食含量的胰岛素剂量
-
Application No.: US12539499Application Date: 2009-08-11
-
Publication No.: US08258095B2Publication Date: 2012-09-04
- Inventor: Anders Hasager Boss , Richard Petrucci , Campbell Howard , Alfred Mann
- Applicant: Anders Hasager Boss , Richard Petrucci , Campbell Howard , Alfred Mann
- Applicant Address: US CA Valencia
- Assignee: MannKind Corporation
- Current Assignee: MannKind Corporation
- Current Assignee Address: US CA Valencia
- Agency: K&L Gates LLP
- Agent Louis C. Cullman; Brent A. Johnson
- Main IPC: A61P3/10
- IPC: A61P3/10 ; A61K38/00
Abstract:
Disclosed herein are improved methods of treating hyperglycemia with a combination of an ultrarapid acting insulin and insulin glargine comprising prandial administration of the ultrarapid insulin, and administration of a first dose of insulin glargine within 6 hours of waking for a day.
Public/Granted literature
- US20100035795A1 USE OF ULTRARAPID ACTING INSULIN Public/Granted day:2010-02-11
Information query
